Cantourage Group SE
HIGH | XMIL
Overview
Corporate Details
- ISIN(s):
- DE000A3DSV01
- LEI:
- 3912003NCTLO6YHA9V48
- Country:
- Germany
- Address:
- Feurigstraße 54, 10827 Berlin
- Website:
- https://www.cantourage.com/
- Sector:
- Consumer Staples
- Industry:
- Tobacco
Description
Cantourage is a publicly listed, leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under the stock ticker “HIGH”.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-20 07:51 |
Earnings Release
Cantourage achieves strong and profitable growth in the first quarter of 2025
|
English | 7.4 KB | |
| 2025-05-15 07:07 |
Earnings Release
Cantourage achieves another record revenue: EUR 11.1 million in April 2025
|
English | 6.6 KB | |
| 2025-04-11 09:03 |
Earnings Release
Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 202…
|
English | 6.8 KB | |
| 2025-04-10 08:52 |
Earnings Release
Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 for the fi…
|
English | 9.0 KB | |
| 2025-03-11 08:31 |
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
|
German | 7.6 KB | |
| 2025-03-10 08:31 |
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
|
German | 7.6 KB | |
| 2025-01-16 07:30 |
Earnings Release
Legalization of cannabis brings strong growth: Cantourage Group SE increases it…
|
English | 10.0 KB | |
| 2025-01-15 07:31 |
Earnings Release
Cantourage Group SE ubertrifft Prognose und steigert Umsatz um 118 % auf EUR 51…
|
German | 8.0 KB | |
| 2025-01-15 07:30 |
Earnings Release
Legalization of cannabis brings strong growth: Cantourage Group SE increases it…
|
English | 11.2 KB | |
| 2025-01-14 07:31 |
Earnings Release
Cantourage Group SE ubertrifft Prognose und steigert Umsatz um 118 % auf EUR 51…
|
German | 8.0 KB | |
| 2024-12-20 08:00 |
Regulatory News Service
Cantourage Group SE exports medical craft cannabis for the first time to the gr…
|
English | 10.6 KB | |
| 2024-12-19 08:00 |
Regulatory News Service
Cantourage Group SE exports medical craft cannabis for the first time to the gr…
|
English | 10.6 KB | |
| 2024-12-13 08:00 |
Earnings Release
Cantourage Group SE verzeichnet starke Geschaftsentwicklung im November und erh…
|
German | 11.1 KB | |
| 2024-12-12 08:00 |
Earnings Release
Cantourage Group SE verzeichnet starke Geschaftsentwicklung im November und erh…
|
German | 11.1 KB | |
| 2024-12-06 07:59 |
Earnings Release
Cantourage Group SE erhoht Jahresprognose fur 2024 aufgrund der Beschleunigung …
|
German | 8.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-02 | Think.Health Projekt M GmbH & Co. KG | Close relation | Sell | None | 72,010.80 EUR |
| 2024-11-25 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 200,000.00 EUR |
| 2024-09-13 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 105,000.00 EUR |
| 2024-07-18 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 140,000.00 EUR |
| 2024-06-06 | HOFY4 GmbH | Close relation | Sell | None | 345,000.00 EUR |
| 2024-05-27 | HOFY4 GmbH | Close relation | Sell | None | 7,400.00 EUR |
| 2024-05-17 | HOFY4 GmbH | Close relation | Sell | None | 140,000.00 EUR |
| 2024-05-17 | HOFY4 GmbH | Close relation | Sell | None | 1,080.00 EUR |
| 2024-02-21 | HOFY4 GmbH | Close relation | Sell | None | 63,205.88 EUR |
| 2024-02-14 | Think.Health Projekt M GmbH & Co. KG | Close relation | Sell | None | 82,415.57 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Badeco Adria d.d. Sarajevo | Bosnia and Herzegovina | FDSS | |
|
British American Tobacco PLC | United Kingdom | BATS | |
|
Cannovum Cannabis AG | Germany | 27N0 | |
|
CHILL BRANDS GROUP PLC | United States of America | CHLL | |
|
Globrands Group Ltd. | Israel | GLRS | |
|
Imperial Brands PLC | United Kingdom | IMB | |
|
Karelia Tobacco Company S.A. | Greece | KARE | |
| Nikotiana BT Holding AD | Bulgaria | HNIC | ||
|
Philip Morris CR A.S. | Czechia | TABAK | |
|
Philip Morris Operations a.d. | Serbia | DINNP |